Status:
RECRUITING
Impact of a Single Versus Multiple Visits on the Cervical Cancer Screening Completeness, Feasibility and Acceptability Among Women Living With HIV in Cameroon
Lead Sponsor:
Institut de Recherche pour le Developpement
Collaborating Sponsors:
Ecole Polytechnique Fédérale de Lausanne
Centre Pasteur du Cameroun
Conditions:
Cervical Cancer Screening
HIV
Eligibility:
FEMALE
25-49 years
Phase:
NA
Brief Summary
Context. Cervical cancer (CC) is a leading cause of death among women living with HIV (WLHIV) in resource-limited settings. Yet, effective methods for screening and preventing CC are available. The re...
Detailed Description
Context. Cervical cancer (CC) is a leading cause of death among women living with HIV (WLHIV) in resource-limited settings. There is compelling evidence that screening for human papillomavirus (HPV) i...
Eligibility Criteria
Inclusion
- HIV infection
- receiving antiretroviral therapy
- living in the department of the study hospital
Exclusion
- ongoing pregnancy
- hysterectomy
- treatment of cervical lesion in the past 12 months
- Expected follow-up difficulties: planned absence that could interfere with the participation in the study (e.g., travel abroad, relocation, imminent transfer, etc.);
- Any pathology or concomitant treatment which, in the opinion of the investigators, contraindicates participation or prevents satisfactory participation in the study Inclusion deferred if
- menstrual bleeding
- post-partum (\<12 weeks after delivery)
- clinicla signs of cervical or pelvic infection
Key Trial Info
Start Date :
December 12 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2027
Estimated Enrollment :
1422 Patients enrolled
Trial Details
Trial ID
NCT07177170
Start Date
December 12 2024
End Date
May 1 2027
Last Update
September 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Foumban hospital
Foumban, Cameroon